Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • ED Files fresh charge...

    ED Files fresh charge sheet in Rs 50-billion Sterling Biotech scam

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-25T09:15:22+05:30  |  Updated On 25 Oct 2018 9:15 AM IST
    ED Files fresh charge sheet in Rs 50-billion Sterling Biotech scam

    New Delhi: The Enforcement Directorate (ED) has recently filed its supplementary charge sheet in a Delhi court in the over Rs 50 billion money laundering case involving Gujarat-based Sterling Biotech Tech.


    The agency has filed the fresh supplementary probe report before Additional Sessions Judge Satish Kumar Arora.


    In its earlier charge sheet, ED had accused the company of taking loans of over Rs 50 billion from a consortium led by Andhra Bank which had turned into non-performing assets (NPAs) or bad loans.


    Earlier Medical Dialogues has reported that The Enforcement Directorate had attached assets worth Rs 5.4 crore in connection with its probe in an alleged Rs 5,700-crore bank loan fraud case linked to a Gujarat-based pharmaceutical company.


    A provisional order for attachment of the assets was issued by the agency under the Prevention of Money Laundering Act (PMLA).


    Read Also: Bank fraud: ED attaches Rs 5.4 crore assets in Sterling biotech case

    Andhra Bankbad loansEDEnforcement DirectorateNon-Performing AssetsPMLAPrevention of Money Laundering ActSatish Kumar AroraSterling Biotech Tech
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok